1. Electrochemical sensor for leukemia drug imatinib determination in urine by adsorptive striping square wave voltammetry using modified screen-printed electrodes;Rodríguez;Electrochim. Acta,2018
2. Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance;Rezende;Rev. Bras. Hematol. Hemoter.,2013
3. D.R. Gandara, B. Piperdi, W.V. Walsh, A Randomized Phase II Study of Schedule-Modulated Concomitant Pemetrexed (Alimta®) and Erlotinib (Tarceva®) vs Single Agent Pemetrexed (Alimta®) in Patients with Progressive or Recurrent Non-small Cell Lung Cancer (NSCLC).
4. A case of imatinib-induced erythrodermia;Bulur;Turkderm Turk. Arch. Dermatol. Venereol.,2014
5. Serum concentration of erlotinib and its correlation with outcome and toxicity in patients with advanced-stage NSCLC;Fiala;Anticancer Res.,2017